GB2064336A — Device for dispensing medicaments
Assigned to Glaxo Group Ltd · Expires 1981-06-17 · 45y expired
What this patent protects
A device by which powdered medicaments can be orally or nasally administered to a patient comprises a body shell (1) defining a portion of a chamber (2). A nozzle or mouthpiece (3) is located at the forward end of the body shell. The body shell is open at the rear end. A sleeve (…
USPTO Abstract
A device by which powdered medicaments can be orally or nasally administered to a patient comprises a body shell (1) defining a portion of a chamber (2). A nozzle or mouthpiece (3) is located at the forward end of the body shell. The body shell is open at the rear end. A sleeve (7) is fitted on the outside of the rear end portion of the body shell (1) and is rotatable and axially movable with respect to it. The sleeve has a rear wall (8) which closes the open rear end of the chamber (2). A capsule retaining means (11) extends through the rear wall (8) of the sleeve into the chamber. The capsule retaining means has an external entry opening for a capsule at the rear of the sleeve. An abutment (13) is fixed inside the chamber (2) in such a position with respect to the retaining means (11) that a capsule retained in the retaining means and projecting from it into the chamber will engage the abutment when the sleeve is rotated with respect to the body shell. This separates the projecting portion of the capsule from the remainder of the capsule. A grid or guard (4) prevents the separated portion of the capsule from passing through the nozzle or mouthpiece (3). An air inlet opening (14) extends through the rear wall of the sleeve into the chamber (2). <IMAGE>
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.